insights_auto
Why is GANX down 5.76%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$0.98
arrow_downward
-5.76%(-0.060) 1D
Nov 16, 12:43:28 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.01
High
$1.08
Low
$0.95
Mkt. cap
43.64M
Avg. vol.
527.99K
Volume
433.40K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.01
High
$1.08
Low
$0.95
Mkt. cap
43.64M
Avg. vol.
527.99K
Volume
433.40K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
marketscreener.com
·
16 minutes ago
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
17 minutes ago
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Benzinga
·
57 minutes ago
Forget Nvidia — S&P 500's 8,900 Target Puts These ETFs in Play - State Street SPDR S&P 500 ETF Trust (ARC
BigGo Finance
·
3 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com